Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Upstart Holdings Inc (UPST) vs Zoetis Inc (ZTS) Price & Performance

Upstart Holdings IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Upstart Holdings Inc vs Zoetis Inc — how do they compare? Upstart Holdings Inc trades at $24.1 (market cap $2.35B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 12.9× Upstart Holdings Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Upstart Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Upstart Holdings Inc for 39 Days and Zoetis Inc for 70 Days on average.

UPSTZTS
Market Cap
$2.35B$30.20B
Volume
4,203,3376,175,327
Sector
FinancialsHealth
52-Week High
$52.74$147.53
52-Week Low
$22.81$69.09
Typical Hold Time
39 Days70 Days
Enterprise Value
$3.88B$37.76B
Dividend Yield
—2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Upstart Holdings Inc

UPST trades at $24.19, up 0.71% with bearish technical signals despite recent partnership expansions. The company shows improving fundamentals with revenue growing to $1.02B in 2025 and achieving profitability with $53.6M net income. However, recent earnings misses and negative operating cash flow of -$147.73M raise concerns. Analyst sentiment remains divided with a $39.50 price target suggesting 63% upside potential from current levels.

The stock presents a high-risk opportunity with significant upside potential if the company can sustain revenue growth and improve cash flow generation. Key risks include ongoing earnings volatility, credit market sensitivity, and high debt levels. The AI lending platform's expansion into HELOC and auto lending could drive future growth, but execution remains critical for investor confidence.

Zoetis Inc

Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.

Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

UPST
73% Buy27% Sell
Avg holding period · 39 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Upstart Holdings Inc

Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.

Read more on UPST →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →